SANTOS DAVID A (EVP, Chief Commercial Officer) sold 7.0% of their position (3.92K shares) of RIGEL PHARMACEUTICALS INC on the open market
Open‑market sale worth $83.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/6/2025ACC: 0000905148-25-000412
Officer· EVP, Chief Commercial Officer
Since Aug 2020
-3.92K
Net shares
Net seller
$83.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.92K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.13K
Price / share
$20.92
Trade value
$44.46K
% of position
3.8%
2/4/2025
55.63K→53.50K
Common Stock
Direct
Shares
−1.80K
Price / share
$21.93
Trade value
$39.38K
% of position
3.4%
2/5/2025
53.50K→51.70K
Total
Net shares
−3.92K
Net value
-$83.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | S · Sale | −2.13K | $20.92 | $44.46K | 3.8% | 55.63K | 53.50K |
| Common Stock Direct | 2/5/2025 | S · Sale | −1.80K | $21.93 | $39.38K | 3.4% | 53.50K | 51.70K |
| Total | −3.92K | -$83.84K | ||||||
Derivative Transactions0
No derivative transactions reported